|
|
Analysis of nutritional risk and application of nutritional support in 80 patients with malignant tumor during chemoradiotherapy |
1 The Radiotherapy Ward of Peking University Cancer Hospital, Beijing 100142; 2 Beijing Information Management School, Beijing 100080;3 The Clinical Nutrition Department of Peking University Cancer Hospital, Beijing 100142 |
|
|
Abstract Abstract: Objective To explore the prevalence of nutritional risk, undernutrition and application of nutritional support in cancer patients during chemoradiotherapy. Methods A total of 80 were enrolled from March 2010 to February 2011 .Nutritional risk screening(NRS 2002) was performed on first 48 hours incharge and the discharged day, Nutritional support was evaluated on the discharged day too. Results Overall prevalence of nutritional risk and undernutrition on first 48 hours incharge was 38.75% , 23.75% respectively, the prevalence of nutritional risk and undernutrition on the discharged day was 81.25%,40% respectively. Totally 20 patients with NRS≥3 were received nutritional support. Grade 3 or higher myelosuppression occurrence were 29%(9/31), 26.5%(13/49) among patients with NRS≥3 and NRS <3 respectively . Grade 4 anemia and thrombocytopenia only occurred in patients with NRS≥3. Conclusions A large proportion of cancer patients is at nutritional risk or undernutrition during chemoradiotherapy .The application of nutrition support is inappropriate. Assessing the nutrition risk dynamically, and carrying out effective nutrition support are the key points to prevent chemoradiotherapy patients from undernutrition.
|
|
|
|
|
[1] |
SUN Xue-hua, ZHOU Fu-xiang. Current problems and thinkings on the cancer metabolic modulation therapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 287-294. |
[2] |
1,4 SONG Meng-meng,2CHEN Zhe-wen,3 LI Ye,1,4 SONG Chun-hua,5SHI Han-ping,6MIAO Ming-yong. Advances in anti-tumor effect of mannose[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 283-286. |
[3] |
1YAO Ke-qing, 1WANG Su, 1CHEN Shuang, 1SUN Yan-teng, 1LIU Qing-yang, 1CHEN Tao,1LIU Xue-hui, 2CONG Ming-hua. Application of individualized nutrition diagnosis and intervention in patients with advanced cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 305-309. |
[4] |
1,2ZHU Ming-xing, 1WU Chang-peng, 3YIN Liang-yu,1LU Zong-liang, 1LI Na,1LIU Jie, 1GUO Jing, 1XU Hong-xia. L-carnitine improves skeletal muscle cell atrophy of cancer cachexia by regulating lipid metabolism[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 320-325. |
[5] |
ZHANG Xiao-wei, SHI Han-ping. Non-maligment bowel obstruction in the context of advanced cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 361-364. |
[6] |
1,2GAO Chao, 1,2WANG Sheng-hao, 1,2ZHU Wen-wei, 1,2CHEN Jin-hong,1,2LU Ming, 1,2,3QIN Lun-xiu. Acetyl-CoA metabolism and cancer metastasis[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 376-381. |
|
|
|
|